Bobby Green, a community oncologist and chief medical officer at Flatiron Health, and Sumit Shah, head of digital health at Stanford Cancer Center, dive into the impact of COVID-19 on oncology. They discuss the shift to virtual care and how patients are balancing risks with treatment needs. Twitter's role in real-time medical insights is highlighted, alongside the surge of virtual clinics. Challenges of telemedicine, patient technology struggles, and the FDA's adaptability in clinical trials reveal how technology is reshaping cancer care in these trying times.
